Joel Greenblatt's SLS Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 74,344 shares of SELLAS Life Sciences Group, Inc. (SLS) worth $1.1 M, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Joel Greenblatt has initiated a new position in SLS, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's SELLAS Life Sciences Group (SLS) Holding Value Over Time
Track share changes against reported price movement
Quarterly SELLAS Life Sciences Group (SLS) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +74,344 | New Buy | 74,344 | $14.76 |
Joel Greenblatt's SELLAS Life Sciences Group Investment FAQs
Joel Greenblatt first purchased SELLAS Life Sciences Group, Inc. (SLS) in Q2 2026, acquiring 74,344 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held SELLAS Life Sciences Group, Inc. (SLS) for 1 quarters since Q2 2026.
Joel Greenblatt's largest addition to SELLAS Life Sciences Group, Inc. (SLS) was in Q2 2026, adding 74,344 shares worth $1.1 M.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 74,344 shares of SELLAS Life Sciences Group, Inc. (SLS), valued at approximately $1.1 M.
As of the Q2 2026 filing, SELLAS Life Sciences Group, Inc. (SLS) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in SELLAS Life Sciences Group, Inc. (SLS) was 74,344 shares, as reported at the end of Q2 2026.